Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Willis Lease Finance (WLFC) Change in Accured Expenses (2017 - 2025)

Willis Lease Finance's Change in Accured Expenses history spans 16 years, with the latest figure at -$11.1 million for Q3 2025.

  • For Q3 2025, Change in Accured Expenses fell 512.7% year-over-year to -$11.1 million; the TTM value through Sep 2025 reached -$3.3 million, down 116.24%, while the annual FY2024 figure was $20.7 million, 20.66% up from the prior year.
  • Change in Accured Expenses for Q3 2025 was -$11.1 million at Willis Lease Finance, down from $22.6 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $52.2 million in Q1 2024 and bottomed at -$43.3 million in Q2 2024.
  • The 5-year median for Change in Accured Expenses is $2.2 million (2021), against an average of $1.4 million.
  • The largest annual shift saw Change in Accured Expenses soared 1044.75% in 2022 before it plummeted 4238.74% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$11.2 million in 2021, then soared by 123.6% to $2.7 million in 2022, then surged by 232.73% to $8.8 million in 2023, then increased by 3.88% to $9.2 million in 2024, then tumbled by 221.61% to -$11.1 million in 2025.
  • Per Business Quant, the three most recent readings for WLFC's Change in Accured Expenses are -$11.1 million (Q3 2025), $22.6 million (Q2 2025), and -$23.9 million (Q1 2025).